Acutaas Chemicals inaugurated a new pilot plant at its Unit 1 facility in Sachin, Surat, on September 4, 2026. The state-of-the-art facility is designed to support research and development for new product trials and the scale-up of high-potency active pharmaceutical ingredient (API) intermediates.

Facility details

The new plant includes a dedicated area with Occupational Exposure Band (OEB) 4 containment. This infrastructure enables the company to undertake development and validation of highly potent intermediates used in manufacturing high-potency APIs. The facility serves as an intermediate step between laboratory-scale synthesis and full commercial production.

Strategic significance

High-potency APIs are critical components in targeted therapies, including oncology treatments. By establishing a dedicated pilot plant with stringent containment protocols, Acutaas Chemicals signals its intent to build capabilities in this technically demanding segment. The facility allows for process optimisation and scale-up validation before large-scale manufacturing commences.

The company disclosed this development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Acutaas Chemicals Limited has issued the notice for its 19th Annual General Meeting (AGM), scheduled for September 24, 2026. The meeting will address the final dividend for FY26, board appointments, and significant related party transactions.

The company confirmed that dividend payments will be subject to withholding tax as per the Income-tax Act, 2025, effective from April 1, 2026. The record date for determining dividend entitlement remains September 17, 2026. If declared, the dividend will be paid within 30 days of the AGM.

Tax Deduction Guidelines

For resident individual shareholders, TDS is levied at 10% if a valid Permanent Account Number (PAN) is registered. The rate rises to 20% under Section 397(2) of the Act if PAN details are missing or not linked to Aadhaar. No tax is deducted if the total dividend received does not exceed ₹10,000 or if shareholders submit Form 121 meeting eligibility conditions.

Resident non-individuals, including insurance companies and mutual funds, can claim exemption by providing self-declarations and relevant registration certificates. Non-resident shareholders are subject to a withholding tax of 20% plus applicable surcharge and cess. However, they may avail beneficial rates under Double Taxation Avoidance Agreements (DTAA) by submitting Form 41, a Tax Residency Certificate, and other required documents.

Shareholders must submit necessary documents, such as Form 121 or DTAA certificates, by September 15, 2026. Late submissions will result in TDS being deducted at the higher statutory rate. Shareholders can upload documents via the Registrar and Transfer Agent’s portal or email them to the designated address.

Capital Expenditure Plans

During the board meeting held on August 22, 2026, Acutaas Chemicals approved a capital expenditure plan of up to ₹212 crore. The investment aims to establish manufacturing facilities for electronic grade chemicals in Gujarat. The project targets a production capacity of up to 81,000 metric tonnes per annum.

The company plans to complete this capacity addition by the end of FY27-28. Financing for the outlay will come from internal accruals, bank finance, or other permissible methods. The expansion may be undertaken by the parent company or through its Indian subsidiaries.

Board and Governance Updates

The board recommended the re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Non-Executive Independent Director. Both appointments are for five-year terms starting February 8, 2027, subject to shareholder approval at the AGM. Mr. Chetankumar C. Vaghasia also retires by rotation and offers himself for re-appointment.

Additionally, the board approved extending the benefits of the Ami Organics Employees Stock Option Scheme 2023 to eligible employees of the company’s Indian subsidiaries. This proposal also requires shareholder approval at the AGM.

Related Party Transactions and Loans

The AGM notice seeks approval for material related party transactions with subsidiary Acutaas Chemicals Electrolytes Private Limited (ACEPL). Since May 19, 2026, Acutaas Chemicals holds 90% equity in ACEPL following a preferential issue. The company seeks omnibus approval for transactions up to ₹2,900 million until the next AGM.

Furthermore, the company seeks special resolution approval to advance loans or provide guarantees to ACEPL up to ₹1,000 million outstanding at any point in time. As of June 30, 2026, ₹142.4 million was outstanding on account of loans given to ACEPL. These facilities are intended for ACEPL's principal business activities, including capital expenditure and working capital requirements.

Dividend and AGM Details

The company published advertisements in the Financial Express (English and Gujarati editions) on August 24, 2026, to notify shareholders of the upcoming event. The dividend intimation was issued pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE00FF01025/86ac93cb-9b07-4c1a-911a-765a79f90472.pdf